Fundraising FoxVesalius Biocapital Partners — Full Portfolio
22 tracked investments · listed companies and verified rows first
Complix develops therapeutic biologics based on Alphabody technology targeting viral diseases, oncology, and autoimmune conditions.
AI & Machine LearningBiotechDeep TechMedical Devices
Co-investorsPMVAndera PartnersGimvOmnes Capital
Digital Surgery develops pulsed field ablation technologies for the treatment of atrial fibrillation, offering safer and more effective procedural options for cardiac patients.
AI & Machine LearningDigital HealthMedical Devices
Co-investors8VCBalderton CapitalXR InvestBlackRockFrstIndex Ventures+4 more
Exact Imaging develops the ExactVu micro-ultrasound platform, a 29 MHz imaging system that lets urologists perform real-time targeted and systematic prostate biopsies within a standard workflow.
HardwareHealthtechMedical DevicesMarkham, CA
Harold Wodlinger(Director)inRandy AuCoin(President & CEO)inRob Sandler(Executive Officer)inJerrold Wen(Executive Officer)in
BoardWilliam Wortman(Director)Gaston Matthyssens(Director)
Co-investorsiGan PartnersLumira VenturesPMVVenture Ontario
Genkyotex was a developer of NOX inhibitor therapeutics, now owned by Calliditas Therapeutics AB.
Biotech
Co-investorsAndera PartnersMC Healthcare Ventures
Genomic Vision is a genome analysis company whose Molecular Combing technology characterizes DNA at single-molecule resolution for quality control in bioproduction and cell and gene therapy, as well as for drug discovery research.
AI & Machine LearningBiotechMedical Devices
Aaron Bensimon(Chairman of the Executive Board)inFlorence Allouche(Chairman of the Supervisory Board)in
Humedics develops LiMAx, a breath analysis technology for rapid and precise measurement of liver function, enabling doctors to make tailored treatment decisions at the bedside.
BiotechDigital HealthHealthtechMedical DevicesBerlin, DE
Karsten Heyne(Co-founder)inMartin Stockmann(Co-founder)Chalom Sayada(CEO / Managing Director)
Co-investorsKfWSeventure Partners
Ncardia develops induced pluripotent stem cell (iPSC) technologies and services for drug discovery, safety testing, and regenerative medicine applications.
AI & Machine LearningBiotechDeep TechHealthtechMedical Devices
Stefan Braam(Co-founder & Chief Technical Officer)inProf. Dr. MummeryProf. Dr. PassierHerman SpoldersJason Conner(Chief Executive Officer)inJeroen de Groot(Chief Operation Officer Early Discovery)in
Co-investorsÉpimède
OMEICOS is a biotech company developing small-molecule therapeutics based on synthetic analogues of omega-3 fatty acid derived epoxyeicosanoids (17,18-EEQ) for cardiovascular, inflammatory, and rare mitochondrial diseases.
BiotechHealthtechBerlin, DE
Robert Fischer(CEO/CSO & Co-Founder)inKaren Uhlmann(Vice President Operations & IP, Co-Founder)inWolf-Hagen Schunck(Co-Founder)John R. Falck(Co-Founder)
Co-investorsRemiges Ventures, Inc.Forbion
Aptar Digital Health is a division of Aptar Pharma that designs and manufactures drug delivery systems and digital health solutions for the pharmaceutical and healthcare industries.
Digital HealthHealthtechMedical DevicesSaaS
Co-investorsEisai Innovation, Inc.KaristaSanofi Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ActivaeroAmakemApitopeBiencaFf PharmaceuticalsFoveaOgedaProfibrixPrometheraSkyline DiagnosticsSofthaleTrineanTrodmedical
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.